Moderna
MRNA
#1630
Rank
HK$75.47 B
Marketcap
HK$195.21
Share price
-2.41%
Change (1 day)
-75.62%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of December 2024 : HK$84.74 Billion

According to Moderna 's latest financial reports the company has HK$84.74 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$HK$84.62 B-21.78%
2023-12-31$HK$108.20 B-27.58%
2022-12-31$HK$149.41 B35.46%
2021-12-31$HK$110.29 B455.56%
2020-12-31$HK$19.85 B116.99%
2019-12-31$HK$9.14 B-23.65%
2018-12-31$HK$11.98 B145.28%
2017-12-31$HK$4.88 B-25.16%
2016-12-31$HK$6.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$0.59 B-99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$360.49 B 325.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.29 Billion-100.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.52 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$343.03 B 304.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$0.43 B-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$555.76 B 555.81%๐Ÿ‡บ๐Ÿ‡ธ USA